Crossmark

A practical synthesis of YZD-7082B, a novel orally bioavailable selective estrogen receptor degrader (SERD) for the treatment of ER+ breast cancer

Crossref DOI link: https://doi.org/10.1007/s11030-025-11154-1

Published Online: 2025-03-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

He, Yongqi https://orcid.org/0009-0007-7924-2799
Leng, Xin-Yu https://orcid.org/0000-0002-3261-271X
Wang, Runying

Sun, Lulu

Zhang, Dan https://orcid.org/0000-0003-0200-8527
Yang, Yushe https://orcid.org/0000-0002-1007-2492
License Information

Text and Data Mining valid from 2025-03-16

Version of Record valid from 2025-03-16
More Information

Article History

Received: 12 February 2025

Accepted: 1 March 2025

First Online: 16 March 2025

Declarations

:

: The authors declare no competing interests.